ClinicalTrials.gov
public full text
Public Domain
Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs
The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study will also evaluate genetic risk and brain structure as potential predictors of mental decline.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- NSAID use is associated with lower dementia and Alzheimer disease prevalence and slower cognitive decline: A retrospective longitudinal analysis of the NACC cohort#410913
- A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease#844223
- The Gut-Brain Axis in Alzheimer’s: From Microbiota Genetics to Stigmasterol’s Neuroprotection Mechanism.#151439
- La influencia de la neuroplasticidad en el Alzheimer#251812
- Serial failure of the brain clearance continuum in Alzheimer's disease: mechanisms and therapeutic perspectives.#395897
Record · ID 884203
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive